"La clinique Axium, située en plein cœur de la ville d’Aix-en-Provence, est un établissement pluridisciplinaire d’hospitalisation privée. Elle est dotée d’un plateau technique de haut niveau comprenant : Un bloc central composé de 14 salles d’interventions ; Un service d’imagerie ; Un secteur d’endoscopie ; Un secteur d’ophtalmologie ; Un secteur SOS main ouvert 24/24h 7j/7 ; Un service de réanimation - soins continus et de médecine ; Un GCS Axium-Rambot qui traitent les maladies cardiovasculaires avec : Un secteur cardiologie interventionnelle ; Un service d’unité de soins intensif cardiologie et de médecine cardiologie."

During the past decade, Clinique Axium conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique Axium" #1 sponsor was "CeloNova BioSciences, Inc." with 3 trials, followed by "Biotronik AG" with 2 trials sponsored, "Biosensors Europe SA" with 1 trials sponsored, "Biotronik SE & Co. KG" with 1 trials sponsored and "Concept Medical Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Axium" #1 collaborator was "AlpinARC" with 1 trials as a collaborator, "Biotronik France" with 1 trials as a collaborator and "EVAMED" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Axium" are "Coronary Artery Disease" (4 trials), "Acute Coronary Syndrome" (2 trials), "ACS - Acute Coronary Syndrome" (1 trials), "Adenocarcinoma" (1 trials) and "Adenosquamous Carcinoma" (1 trials). Many other conditions were trialed in "Clinique Axium" in a lesser frequency.

Most popular intervention types in "Clinique Axium" are "Device" (10 trials), "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "COBRA PzF" (2 trials), "Abluminus DES+ Sirolimus Eluting Stent System (SES)" (1 trials), "Antiplatelet Drug" (1 trials), "BioFreedom™ Drug Coated Coronary Stent System" (1 trials) and "Biosensors BioFreedom BA9 Drug Coated Coronary Stent" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Axium" are 13 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Clinique Axium". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Clinique Axium, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Axium, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".

Clinique Axium has several departments that took part in Clinical trials: "Clinique AXIUM Centre de cardiologie" - 2 trials